Skip to main content
PMC home page
Annals of the Rheumatic Diseases logoLink to Annals of the Rheumatic Diseases
. 2003 Nov;62(11):1083–1087. doi: 10.1136/ard.62.11.1083

Endothelial nitric oxide synthase gene polymorphisms in Behçet's disease and rheumatic diseases with vasculitis

J Kim 1, H Chang 1, S Lee 1, J Kim 1, K Kim 1, S Lee 1, W Chung 1
PMCID: PMC1754357  PMID: 14583572

Abstract

Objective: To assess potential associations between Korean Behçet's disease (BD) or other rheumatic diseases with vasculitis and two polymorphisms of the endothelial nitric oxide synthase (eNOS) gene, which include the Glu298Asp polymorphism in exon 7 and a variable number of tandem repeats (VNTR) polymorphism in intron 4.

Methods: 65 patients with BD, 27 with rheumatic diseases with vasculitis, and 80 controls were studied. Analyses of the Glu298Asp polymorphism in exon 7 and VNTR polymorphism in intron 4 of the eNOS gene were made by the polymerase chain reaction (PCR)-restriction fragment length polymorphism technique and PCR genotyping, respectively. Additionally, HLA-B51 typing was performed in the BD group and controls by a two step PCR sequence-specific primers method.

Results: Significant differences in Glu298Asp genotype frequencies were found between the BD or vasculitis groups and the controls (BD group v controls: pcorr=0.006; vasculitis group v controls: p<0.001). The Asp298 frequency was much higher in the BD and vasculitis groups than in the controls. Even after stratification of the BD group based on the results of HLA-B51 testing, a significant association of the Glu298Asp polymorphism was still found (p=0.002, Mantel-Haenszel weighted odds ratio 4.3, 95% confidence interval 1.7 to 10.9). Distribution of the genotype frequencies in two eNOS gene polymorphisms was similar in connective tissue diseases-associated vasculitis and primary vasculitic syndromes. In contrast, distribution of alleles and genotypes of VNTR polymorphism did not differ between BD or vasculitis groups and the controls.

Conclusion: The Glu298Asp polymorphism in exon 7 of the eNOS gene seems to be a susceptibility gene for Korean BD and other rheumatic diseases.

Full Text

The Full Text of this article is available as a PDF (248.1 KB).

Figure 1 .

Figure 1

Open in a new tab

Analysis of the Glu298Asp polymorphism in exon 7 of the eNOS gene. Three kinds of restriction fragments are shown after digestion with Ban II: lane 1, size marker; lane 2, homozygote (Asp/Asp); lane 3, homozygote (Glu/Glu) lane 4, heterozygote (Glu/Asp).

Figure 2 .

Figure 2

Open in a new tab

Analysis of the VNTR polymorphism in intron 4 of the eNOS gene. The band of 420 bp indicates five repeats and the band of 393 bp indicates four repeats of the 27 bp: lane 1, size marker; lane 2, wild type (4b/b); lane 3, four and five repeats heterozygote (4b/a); lane 4, four repeats homozygote (4a/a).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Akar N., Akar E., Cin S., Deda G., Avcu F., Yalçin A. Endothelial nitric oxide synthase intron 4, 27 bp repeat polymorphism in Turkish patients with deep vein thrombosis and cerebrovascular accidents. Thromb Res. 1999 Apr 1;94(1):63–64. doi: 10.1016/s0049-3848(98)00193-5. [DOI] [PubMed] [Google Scholar]
  2. Beckman J. S., Koppenol W. H. Nitric oxide, superoxide, and peroxynitrite: the good, the bad, and ugly. Am J Physiol. 1996 Nov;271(5 Pt 1):C1424–C1437. doi: 10.1152/ajpcell.1996.271.5.C1424. [DOI] [PubMed] [Google Scholar]
  3. Chambers J. C., Haskard D. O., Kooner J. S. Vascular endothelial function and oxidative stress mechanisms in patients with Behçet's syndrome. J Am Coll Cardiol. 2001 Feb;37(2):517–520. doi: 10.1016/s0735-1097(00)01137-2. [DOI] [PubMed] [Google Scholar]
  4. Chang H. K., Kim J. U., Cheon K. S., Chung H. R., Lee K. W., Lee I. H. HLA-B51 and its allelic types in association with Behçet's disease and recurrent aphthous stomatitis in Korea. Clin Exp Rheumatol. 2001 Sep-Oct;19(5 Suppl 24):S31–S35. [PubMed] [Google Scholar]
  5. Chang Hyun Kyu, Cheon Kyeong Soo. The clinical significance of a pathergy reaction in patients with Behcet's disease. J Korean Med Sci. 2002 Jun;17(3):371–374. doi: 10.3346/jkms.2002.17.3.371. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Clancy R. M., Amin A. R., Abramson S. B. The role of nitric oxide in inflammation and immunity. Arthritis Rheum. 1998 Jul;41(7):1141–1151. doi: 10.1002/1529-0131(199807)41:7<1141::AID-ART2>3.0.CO;2-S. [DOI] [PubMed] [Google Scholar]
  7. Creager M. A., Gallagher S. J., Girerd X. J., Coleman S. M., Dzau V. J., Cooke J. P. L-arginine improves endothelium-dependent vasodilation in hypercholesterolemic humans. J Clin Invest. 1992 Oct;90(4):1248–1253. doi: 10.1172/JCI115987. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Dhillon R., Clarkson P., Donald A. E., Powe A. J., Nash M., Novelli V., Dillon M. J., Deanfield J. E. Endothelial dysfunction late after Kawasaki disease. Circulation. 1996 Nov 1;94(9):2103–2106. doi: 10.1161/01.cir.94.9.2103. [DOI] [PubMed] [Google Scholar]
  9. Er H., Evereklioglu C., Cumurcu T., Türköz Y., Ozerol E., Sahin K., Doganay S. Serum homocysteine level is increased and correlated with endothelin-1 and nitric oxide in Behçet's disease. Br J Ophthalmol. 2002 Jun;86(6):653–657. doi: 10.1136/bjo.86.6.653. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Esdaile J. M., Abrahamowicz M., Grodzicky T., Li Y., Panaritis C., du Berger R., Côte R., Grover S. A., Fortin P. R., Clarke A. E. Traditional Framingham risk factors fail to fully account for accelerated atherosclerosis in systemic lupus erythematosus. Arthritis Rheum. 2001 Oct;44(10):2331–2337. doi: 10.1002/1529-0131(200110)44:10<2331::aid-art395>3.0.co;2-i. [DOI] [PubMed] [Google Scholar]
  11. Evereklioglu Cem, Turkoz Yusuf, Er Hamdi, Inaloz H. Serhat, Ozbek Emin, Cekmen Mustafa. Increased nitric oxide production in patients with Behçet's disease: is it a new activity marker? J Am Acad Dermatol. 2002 Jan;46(1):50–54. doi: 10.1067/mjd.2002.118338. [DOI] [PubMed] [Google Scholar]
  12. Gül A. Behçet's disease: an update on the pathogenesis. Clin Exp Rheumatol. 2001 Sep-Oct;19(5 Suppl 24):S6–12. [PubMed] [Google Scholar]
  13. Haznedaroglu I. C., Ozcebe O. I., Ozdemir O., Celik I., Dündar S. V., Kirazli S. Impaired haemostatic kinetics and endothelial function in Behçet's disease. J Intern Med. 1996 Oct;240(4):181–187. doi: 10.1046/j.1365-2796.1996.396853000.x. [DOI] [PubMed] [Google Scholar]
  14. Joannides R., Haefeli W. E., Linder L., Richard V., Bakkali E. H., Thuillez C., Lüscher T. F. Nitric oxide is responsible for flow-dependent dilatation of human peripheral conduit arteries in vivo. Circulation. 1995 Mar 1;91(5):1314–1319. doi: 10.1161/01.cir.91.5.1314. [DOI] [PubMed] [Google Scholar]
  15. Karrar A., Sequeira W., Block J. A. Coronary artery disease in systemic lupus erythematosus: A review of the literature. Semin Arthritis Rheum. 2001 Jun;30(6):436–443. doi: 10.1053/sarh.2001.23498. [DOI] [PubMed] [Google Scholar]
  16. Kiraz S., Ertenli I., Calgüneri M., Oztürk M. A., Haznedaroglu I. C., Altun B., Erman M., Celik I. Interactions of nitric oxide and superoxide dismutase in Behçet's disease. Clin Exp Rheumatol. 2001 Sep-Oct;19(5 Suppl 24):S25–S29. [PubMed] [Google Scholar]
  17. Koç Y., Güllü I., Akpek G., Akpolat T., Kansu E., Kiraz S., Batman F., Kansu T., Balkanci F., Akkaya S. Vascular involvement in Behçet's disease. J Rheumatol. 1992 Mar;19(3):402–410. [PubMed] [Google Scholar]
  18. Lakhanpal S., Tani K., Lie J. T., Katoh K., Ishigatsubo Y., Ohokubo T. Pathologic features of Behçet's syndrome: a review of Japanese autopsy registry data. Hum Pathol. 1985 Aug;16(8):790–795. doi: 10.1016/s0046-8177(85)80250-1. [DOI] [PubMed] [Google Scholar]
  19. Lefer A. M. Nitric oxide: nature's naturally occurring leukocyte inhibitor. Circulation. 1997 Feb 4;95(3):553–554. doi: 10.1161/01.cir.95.3.553. [DOI] [PubMed] [Google Scholar]
  20. Lima Domingos S. N., Sato Emilia I., Lima Valter C., Miranda Fausto, Jr, Hatta Francisca H. Brachial endothelial function is impaired in patients with systemic lupus erythematosus. J Rheumatol. 2002 Feb;29(2):292–297. [PubMed] [Google Scholar]
  21. Manzi S., Meilahn E. N., Rairie J. E., Conte C. G., Medsger T. A., Jr, Jansen-McWilliams L., D'Agostino R. B., Kuller L. H. Age-specific incidence rates of myocardial infarction and angina in women with systemic lupus erythematosus: comparison with the Framingham Study. Am J Epidemiol. 1997 Mar 1;145(5):408–415. doi: 10.1093/oxfordjournals.aje.a009122. [DOI] [PubMed] [Google Scholar]
  22. Marsden P. A., Heng H. H., Scherer S. W., Stewart R. J., Hall A. V., Shi X. M., Tsui L. C., Schappert K. T. Structure and chromosomal localization of the human constitutive endothelial nitric oxide synthase gene. J Biol Chem. 1993 Aug 15;268(23):17478–17488. [PubMed] [Google Scholar]
  23. Mirza G. E., Karakük S., Er M., Güngörmü N., Karakük I., Saraymen R. Tear nitrite and nitrate levels as nitric oxide end products in patients with Behçet's disease and non-Behçet's uveitis. Ophthalmic Res. 2001 Jan-Feb;33(1):48–51. doi: 10.1159/000055641. [DOI] [PubMed] [Google Scholar]
  24. Oemar B. S., Tschudi M. R., Godoy N., Brovkovich V., Malinski T., Lüscher T. F. Reduced endothelial nitric oxide synthase expression and production in human atherosclerosis. Circulation. 1998 Jun 30;97(25):2494–2498. doi: 10.1161/01.cir.97.25.2494. [DOI] [PubMed] [Google Scholar]
  25. Orem A., Vanizor B., Cimşit G., Kiran E., Değer O., Malkoç M. Decreased nitric oxide production in patients with Behçet's disease. Dermatology. 1999;198(1):33–36. doi: 10.1159/000018061. [DOI] [PubMed] [Google Scholar]
  26. Palmer R. M., Ashton D. S., Moncada S. Vascular endothelial cells synthesize nitric oxide from L-arginine. Nature. 1988 Jun 16;333(6174):664–666. doi: 10.1038/333664a0. [DOI] [PubMed] [Google Scholar]
  27. Philip I., Plantefeve G., Vuillaumier-Barrot S., Vicaut E., LeMarie C., Henrion D., Poirier O., Levy B. I., Desmonts J. M., Durand G. G894T polymorphism in the endothelial nitric oxide synthase gene is associated with an enhanced vascular responsiveness to phenylephrine. Circulation. 1999 Jun 22;99(24):3096–3098. doi: 10.1161/01.cir.99.24.3096. [DOI] [PubMed] [Google Scholar]
  28. Prior P., Symmons D. P., Scott D. L., Brown R., Hawkins C. F. Cause of death in rheumatoid arthritis. Br J Rheumatol. 1984 May;23(2):92–99. doi: 10.1093/rheumatology/23.2.92. [DOI] [PubMed] [Google Scholar]
  29. Raza K., Thambyrajah J., Townend J. N., Exley A. R., Hortas C., Filer A., Carruthers D. M., Bacon P. A. Suppression of inflammation in primary systemic vasculitis restores vascular endothelial function: lessons for atherosclerotic disease? Circulation. 2000 Sep 26;102(13):1470–1472. doi: 10.1161/01.cir.102.13.1470. [DOI] [PubMed] [Google Scholar]
  30. Sakane T., Takeno M., Suzuki N., Inaba G. Behçet's disease. N Engl J Med. 1999 Oct 21;341(17):1284–1291. doi: 10.1056/NEJM199910213411707. [DOI] [PubMed] [Google Scholar]
  31. Salvarani Carlo, Boiardi Luigi, Casali Bruno, Olivieri Ignazio, Ciancio Giovanni, Cantini Fabrizio, Salvi Fabrizio, Malatesta Renato, Govoni Marcello, Trotta Francesco. Endothelial nitric oxide synthase gene polymorphisms in Behçet's disease. J Rheumatol. 2002 Mar;29(3):535–540. [PubMed] [Google Scholar]
  32. Schmidt H. H., Nau H., Wittfoht W., Gerlach J., Prescher K. E., Klein M. M., Niroomand F., Böhme E. Arginine is a physiological precursor of endothelium-derived nitric oxide. Eur J Pharmacol. 1988 Sep 13;154(2):213–216. doi: 10.1016/0014-2999(88)90101-x. [DOI] [PubMed] [Google Scholar]
  33. Schmidt H. H., Walter U. NO at work. Cell. 1994 Sep 23;78(6):919–925. doi: 10.1016/0092-8674(94)90267-4. [DOI] [PubMed] [Google Scholar]
  34. Schmitz-Huebner U., Knop J. Evidence for an endothelial cell dysfunction in association with Behçet's disease. Thromb Res. 1984 May 15;34(4):277–285. doi: 10.1016/0049-3848(84)90384-0. [DOI] [PubMed] [Google Scholar]
  35. Shimasaki Y., Yasue H., Yoshimura M., Nakayama M., Kugiyama K., Ogawa H., Harada E., Masuda T., Koyama W., Saito Y. Association of the missense Glu298Asp variant of the endothelial nitric oxide synthase gene with myocardial infarction. J Am Coll Cardiol. 1998 Jun;31(7):1506–1510. doi: 10.1016/s0735-1097(98)00167-3. [DOI] [PubMed] [Google Scholar]
  36. Stichtenoth D. O., Frölich J. C. Nitric oxide and inflammatory joint diseases. Br J Rheumatol. 1998 Mar;37(3):246–257. doi: 10.1093/rheumatology/37.3.246. [DOI] [PubMed] [Google Scholar]
  37. Tesauro M., Thompson W. C., Rogliani P., Qi L., Chaudhary P. P., Moss J. Intracellular processing of endothelial nitric oxide synthase isoforms associated with differences in severity of cardiopulmonary diseases: cleavage of proteins with aspartate vs. glutamate at position 298. Proc Natl Acad Sci U S A. 2000 Mar 14;97(6):2832–2835. doi: 10.1073/pnas.97.6.2832. [DOI] [PMC free article] [PubMed] [Google Scholar]
  38. Tsukada T., Yokoyama K., Arai T., Takemoto F., Hara S., Yamada A., Kawaguchi Y., Hosoya T., Igari J. Evidence of association of the ecNOS gene polymorphism with plasma NO metabolite levels in humans. Biochem Biophys Res Commun. 1998 Apr 7;245(1):190–193. doi: 10.1006/bbrc.1998.8267. [DOI] [PubMed] [Google Scholar]
  39. Uwabo J., Soma M., Nakayama T., Kanmatsuse K. Association of a variable number of tandem repeats in the endothelial constitutive nitric oxide synthase gene with essential hypertension in Japanese. Am J Hypertens. 1998 Jan;11(1 Pt 1):125–128. doi: 10.1016/s0895-7061(97)00419-6. [DOI] [PubMed] [Google Scholar]
  40. Walsh P. S., Metzger D. A., Higuchi R. Chelex 100 as a medium for simple extraction of DNA for PCR-based typing from forensic material. Biotechniques. 1991 Apr;10(4):506–513. [PubMed] [Google Scholar]
  41. Wang X. L., Mahaney M. C., Sim A. S., Wang J., Wang J., Blangero J., Almasy L., Badenhop R. B., Wilcken D. E. Genetic contribution of the endothelial constitutive nitric oxide synthase gene to plasma nitric oxide levels. Arterioscler Thromb Vasc Biol. 1997 Nov;17(11):3147–3153. doi: 10.1161/01.atv.17.11.3147. [DOI] [PubMed] [Google Scholar]
  42. Wang X. L., Sim A. S., Badenhop R. F., McCredie R. M., Wilcken D. E. A smoking-dependent risk of coronary artery disease associated with a polymorphism of the endothelial nitric oxide synthase gene. Nat Med. 1996 Jan;2(1):41–45. doi: 10.1038/nm0196-41. [DOI] [PubMed] [Google Scholar]
  43. Wang X. L., Sim A. S., Wang M. X., Murrell G. A., Trudinger B., Wang J. Genotype dependent and cigarette specific effects on endothelial nitric oxide synthase gene expression and enzyme activity. FEBS Lett. 2000 Apr 7;471(1):45–50. doi: 10.1016/s0014-5793(00)01356-9. [DOI] [PubMed] [Google Scholar]
  44. Wang X. L., Wang J. Endothelial nitric oxide synthase gene sequence variations and vascular disease. Mol Genet Metab. 2000 Aug;70(4):241–251. doi: 10.1006/mgme.2000.3033. [DOI] [PubMed] [Google Scholar]
  45. Yokoyama K., Tsukada T., Matsuoka H., Hara S., Yamada A., Kawaguchi Y. High accumulation of endothelial nitric oxide synthase (ecNOS): a gene polymorphism in patients with end-stage renal disease. Nephron. 1998;79(3):360–361. doi: 10.1159/000045069. [DOI] [PubMed] [Google Scholar]

Articles from Annals of the Rheumatic Diseases are provided here courtesy of BMJ Publishing Group

RESOURCES